Latest News by Industry
SAN FRANCISCO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and full year of fiscal 2022.
"We continue to make progress in bringing the Dolby experience to all the ways people enjoy their content," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While results came in below our expectations, we grew our presence across movies and TV, music, and user-generated content and we are confident in our long-term growth opportunities."
Fourth Quarter Fiscal 2022 Financial Highlights
Full Year Fiscal 2022 Financial Highlights
A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.
Recent Business Highlights
Dividend
Today, Dolby announced a cash dividend of $0.27 per share of Class A and Class B common stock, payable on December 8, 2022, to stockholders of record as of the close of business on November 30, 2022.
Financial Outlook
Dolby’s financial outlook relies on estimates of royalty-based revenue that take into consideration the macroeconomic effect of certain events, including COVID-19, supply chain constraints, and consumer demand for electronic products. In addition, our actual results could differ materially from the estimates we are providing below due in part to the increased uncertainty resulting from these items as well as the geopolitical instability and continuing concerns around inflation and rising interest rates. The uncertainty resulting from these factors has greatly reduced our visibility into our future outlook. To the extent possible, the estimates we are providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that we face, and the section captioned "Risk Factors" in our Annual Report on Form 10-K for fiscal 2022, to be filed on or around the date hereof.
Dolby is providing the following high-level estimates for the full year of fiscal 2023:
Dolby is providing the following estimates for its first quarter of fiscal 2023:
Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss fourth quarter fiscal 2022 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, November 17, 2022. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-844-200-6205 (or dialing 1-929-526-1599 for international callers) and entering confirmation code 357413.
A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, November 17, 2022, until 11:00 p.m. PT on Thursday, November 24, 2022 (2:00 a.m. ET on Friday, November 25, 2022), by dialing 1-866-813-9403 (international callers can access the replay by dialing +44-204-525-0658) and entering the confirmation code 258585. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.
Financial Results
The financial results for the fourth quarter and fiscal year ended September 30, 2022 discussed in this release are subject to the completion of the audit of our year-end financial statements and to adjustment, pursuant to our revenue recognition policies under ASC 606. In accordance with ASC 606, we may be required to recognize revenue between the date of this release and the time at which we issue our audited consolidated financial statements. Any changes to the estimated financial results discussed above as a result of our revenue recognition policies under ASC 606 will be included in our Annual Report on Form 10-K for fiscal 2022.
Non-GAAP Financial Information
To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:
Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.
Amortization of acquisition-related intangibles: We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, we exclude these charges to facilitate an evaluation of our current operating performance and comparisons to our past operating results.
Restructuring charges: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.
Other operating income adjustments: In the second quarter of fiscal 2022, we recorded an expense of $34.4 million related to a one-time settlement and accrual in connection with indemnification requests under commercial agreements that we assumed as part of an acquisition in 2014 related to our cinema products business. We expect this settlement and related accrual to fully resolve this matter. Also, in the first quarter of fiscal 2021, we recorded a one-time gain on the sale of property, which was previously classified as held for sale. The property was 51% owned by the controlling interest, therefore 51% of the gain recognized has been attributed to the controlling interest. We have excluded both of these items as they are unusual, non-recurring events that are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.
Income tax adjustments: We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.
Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.
Forward-Looking Statements
Certain statements in this press release, including, but not limited to, statements relating to Dolby's financial results for the fourth quarter and full year of fiscal 2022, expected financial results for the first quarter of fiscal 2023 and full year fiscal 2023, our ability to expand existing business, navigating challenging periods, pursue our long-term growth opportunities, and advance our other long-term objectives, and future dividend payments are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of COVID-19 and economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; consumer demand for products that incorporate Dolby technologies; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market, including closures or limitations of cinema capacity and resulting adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; temporary Dolby office closures and other actions to protect Dolby’s workforce; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues, such as the conflict between Russia and Ukraine; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that media is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; the completion of the audit of our year-end financial statements, final adjustments and other developments that may arise between now and the time our audited consolidated financial statements are issued; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in our Annual Report on Form 10-K filed on or around the date hereof. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements. Forward-looking statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. We partner with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.
Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories, Inc. in the United States and/or other countries. Other trademarks remain the property of their respective owners.
DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
( in thousands, except per share amounts; unaudited )
| Fiscal Quarter Ended | Fiscal Year Ended | ||||||||||||
| September 30, 2022 | September 24, 2021 | September 30, 2022 | September 24, 2021 | ||||||||||
| Revenue: | |||||||||||||
| Licensing | $ | 249,127 | $ | 265,988 | $ | 1,164,533 | $ | 1,214,147 | |||||
| Products and services | 29,077 | 19,037 | 89,260 | 67,109 | |||||||||
| Total revenue | 278,204 | 285,025 | 1,253,793 | 1,281,256 | |||||||||
| Cost of revenue: | |||||||||||||
| Cost of licensing | 16,234 | 13,935 | 61,597 | 55,421 | |||||||||
| Cost of products and services | 20,945 | 16,764 | 79,763 | 74,604 | |||||||||
| Total cost of revenue | 37,179 | 30,699 | 141,360 | 130,025 | |||||||||
| Gross margin | 241,025 | 254,326 | 1,112,433 | 1,151,231 | |||||||||
| Operating expenses: | |||||||||||||
| Research and development | 62,070 | 61,966 | 261,174 | 253,640 | |||||||||
| Sales and marketing | 90,202 | 98,466 | 358,716 | 332,671 | |||||||||
| General and administrative | 57,065 | 54,193 | 275,315 | 224,161 | |||||||||
| Gain on sale of assets | — | — | — | (13,871 | ) | ||||||||
| Restructuring charges | 4,580 | (664 | ) | 10,623 | 10,240 | ||||||||
| Total operating expenses | 213,917 | 213,961 | 905,828 | 806,841 | |||||||||
| Operating income | 27,108 | 40,365 | 206,605 | 344,390 | |||||||||
| Other income/(expense): | |||||||||||||
| Interest income | 3,338 | 816 | 6,568 | 3,493 | |||||||||
| Interest expense | (139 | ) | (119 | ) | (394 | ) | (479 | ) | |||||
| Other income, net | 667 | 1,996 | 2,500 | 7,108 | |||||||||
| Total other income | 3,866 | 2,693 | 8,674 | 10,122 | |||||||||
| Income before income taxes | 30,974 | 43,058 | 215,279 | 354,512 | |||||||||
| (Provision for)/benefit from income taxes | (3,215 | ) | 1,170 | (31,381 | ) | (36,689 | ) | ||||||
| Net income including controlling interest | 27,759 | 44,228 | 183,898 | 317,823 | |||||||||
| Less: net (income)/loss attributable to controlling interest | (3 | ) | (37 | ) | 189 | (7,596 | ) | ||||||
| Net income attributable to Dolby Laboratories, Inc. | $ | 27,756 | $ | 44,191 | $ | 184,087 | $ | 310,227 | |||||
| Net income per share: | |||||||||||||
| Basic | $ | 0.29 | $ | 0.44 | $ | 1.84 | $ | 3.07 | |||||
| Diluted | $ | 0.28 | $ | 0.42 | $ | 1.81 | $ | 2.97 | |||||
| Weighted-average shares outstanding: | |||||||||||||
| Basic | 97,077 | 101,227 | 99,990 | 101,190 | |||||||||
| Diluted | 98,461 | 104,369 | 101,983 | 104,622 | |||||||||
DOLBY LABORATORIES, INC.
CONSOLIDATED BALANCE SHEETS
( in thousands; unaudited )
| September 30, 2022 | September 24, 2021 | |||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 620,127 | $ | 1,225,380 | ||
| Restricted cash | 8,244 | 7,652 | ||||
| Short-term investments | 189,213 | 38,839 | ||||
| Accounts receivable, net | 243,593 | 232,609 | ||||
| Contract assets, net | 176,093 | 182,316 | ||||
| Inventories, net | 23,549 | 10,965 | ||||
| Prepaid expenses and other current assets | 50,075 | 62,737 | ||||
| Total current assets | 1,310,894 | 1,760,498 | ||||
| Long-term investments | 102,514 | 62,819 | ||||
| Property, plant and equipment, net | 513,481 | 534,381 | ||||
| Operating lease right-of-use assets | 46,530 | 67,128 | ||||
| Goodwill and intangible assets, net | 477,412 | 463,584 | ||||
| Deferred taxes | 183,568 | 156,020 | ||||
| Other non-current assets | 55,149 | 61,257 | ||||
| Total assets | $ | 2,689,548 | $ | 3,105,687 | ||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current liabilities: | ||||||
| Accounts payable | $ | 14,171 | $ | 17,779 | ||
| Accrued liabilities | 230,237 | 262,728 | ||||
| Income taxes payable | 1,265 | 1,334 | ||||
| Contract liabilities | 18,588 | 18,473 | ||||
| Operating lease liabilities | 13,257 | 15,403 | ||||
| Total current liabilities | 277,518 | 315,717 | ||||
| Non-current contract liabilities | 23,203 | 23,713 | ||||
| Non-current operating lease liabilities | 37,685 | 56,715 | ||||
| Other non-current liabilities | 100,122 | 105,310 | ||||
| Total liabilities | 438,528 | 501,455 | ||||
| Stockholders’ equity: | ||||||
| Class A common stock | 53 | 59 | ||||
| Class B common stock | 41 | 41 | ||||
| Retained earnings | 2,297,730 | 2,607,909 | ||||
| Accumulated other comprehensive loss | (51,641 | ) | (10,030 | ) | ||
| Total stockholders’ equity – Dolby Laboratories, Inc. | 2,246,183 | 2,597,979 | ||||
| Controlling interest | 4,837 | 6,253 | ||||
| Total stockholders’ equity | 2,251,020 | 2,604,232 | ||||
| Total liabilities and stockholders’ equity | $ | 2,689,548 | $ | 3,105,687 | ||
DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
( in thousands; unaudited )
| Fiscal Year Ended | ||||||
| September 30, 2022 | September 24, 2021 | |||||
| Operating activities: | ||||||
| Net income including controlling interest | $ | 183,898 | $ | 317,823 | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Depreciation and amortization | 88,461 | 95,860 | ||||
| Stock-based compensation | 114,925 | 99,698 | ||||
| Amortization of operating lease right-of-use assets | 15,148 | 16,897 | ||||
| Amortization of premium on investments | 1,440 | 1,373 | ||||
| Provision for/(benefit from) credit losses | 5,460 | (2,889 | ) | |||
| Deferred income taxes | (29,465 | ) | (37,048 | ) | ||
| Gain on sale of assets | — | (13,871 | ) | |||
| Other non-cash items affecting net income | (5,037 | ) | (5,452 | ) | ||
| Changes in operating assets and liabilities: | ||||||
| Accounts receivable, net | (14,314 | ) | (49,034 | ) | ||
| Contract assets, net | 6,300 | (21,154 | ) | |||
| Inventories | (11,759 | ) | 17,154 | |||
| Operating lease right-of-use assets | 266 | (5,199 | ) | |||
| Prepaid expenses and other assets | 8,760 | 17,165 | ||||
| Accounts payable and accrued liabilities | (33,542 | ) | 44,230 | |||
| Income taxes, net | 8,446 | (2,975 | ) | |||
| Contract liabilities | (413 | ) | 2,361 | |||
| Operating lease liabilities | (15,399 | ) | (11,369 | ) | ||
| Other non-current liabilities | (4,599 | ) | (15,817 | ) | ||
| Net cash provided by operating activities | 318,576 | 447,753 | ||||
| Investing activities: | ||||||
| Purchases of marketable securities | (311,313 | ) | (67,101 | ) | ||
| Proceeds from sales of marketable securities | 9,459 | 10,892 | ||||
| Proceeds from maturities of marketable securities | 108,546 | 53,893 | ||||
| Purchases of property, plant, and equipment | (47,928 | ) | (54,454 | ) | ||
| Proceeds from sale of assets | — | 16,365 | ||||
| Payments for business combinations, net of cash acquired | (38,171 | ) | (4,500 | ) | ||
| Purchases of intangible assets | (11,528 | ) | — | |||
| Purchases of other investments | (5,000 | ) | — | |||
| Net cash used in investing activities | (295,935 | ) | (44,905 | ) | ||
| Financing activities: | ||||||
| Proceeds from issuance of common stock | 57,848 | 122,088 | ||||
| Repurchase of common stock | (530,486 | ) | (245,864 | ) | ||
| Payment of cash dividend | (100,067 | ) | (89,172 | ) | ||
| Distribution to controlling interest | (1,435 | ) | (7,362 | ) | ||
| Shares repurchased for tax withholdings on vesting of restricted stock | (36,418 | ) | (32,205 | ) | ||
| Net cash used in financing activities | (610,558 | ) | (252,515 | ) | ||
| Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | (16,744 | ) | 2,720 | |||
| Net increase/(decrease) in cash, cash equivalents, and restricted cash | (604,661 | ) | 153,053 | |||
| Cash, cash equivalents, and restricted cash at beginning of period | 1,233,032 | 1,079,979 | ||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 628,371 | $ | 1,233,032 | ||
| GAAP to Non-GAAP Reconciliations | ||||||||||||||||
| (in millions, except per share data; unaudited) | ||||||||||||||||
| The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the fourth quarter and fiscal year ended September 30, 2022 and September 24, 2021: | ||||||||||||||||
| Net income: | Fiscal Quarter Ended | Fiscal Year Ended | ||||||||||||||
| September 30, 2022 | September 24, 2021 | September 30, 2022 | September 24, 2021 | |||||||||||||
| GAAP net income | $ | 27.8 | $ | 44.2 | $ | 184.1 | $ | 310.2 | ||||||||
| Stock-based compensation(1) | 27.0 | 24.1 | 114.9 | 99.7 | ||||||||||||
| Amortization of acquisition-related intangibles(2) | 1.8 | 2.7 | 9.1 | 10.2 | ||||||||||||
| Other operating income adjustments | — | — | 34.4 | (6.8 | ) | |||||||||||
| Restructuring charges | 4.6 | (0.7 | ) | 10.6 | 10.2 | |||||||||||
| Income tax adjustments | (8.4 | ) | (9.9 | ) | (33.2 | ) | (40.2 | ) | ||||||||
| Non-GAAP net income | $ | 52.8 | $ | 60.4 | $ | 319.9 | $ | 383.3 | ||||||||
| (1) Stock-based compensation included in above line items: | ||||||||||||||||
| Cost of products and services | $ | 0.4 | $ | 0.5 | $ | 1.7 | $ | 2.1 | ||||||||
| Research and development | 8.6 | 7.3 | 37.1 | 29.7 | ||||||||||||
| Sales and marketing | 9.6 | 8.2 | 41.3 | 36.4 | ||||||||||||
| General and administrative | 8.4 | 8.1 | 34.8 | 31.5 | ||||||||||||
| (2) Amortization of acquisition-related intangibles included in above line items: | ||||||||||||||||
| Cost of licensing | $ | — | $ | 0.7 | $ | 1.5 | $ | 2.8 | ||||||||
| Cost of products and services | 0.9 | 0.9 | 3.1 | 3.6 | ||||||||||||
| Research and development | 0.1 | 0.1 | 0.5 | 0.4 | ||||||||||||
| Sales and marketing | 0.8 | 1.0 | 3.7 | 3.4 | ||||||||||||
| General and administrative | — | — | 0.3 | — | ||||||||||||
| Diluted earnings per share: | Fiscal Quarter Ended | Fiscal Year Ended | ||||||||||||||
| September 30, 2022 | September 24, 2021 | September 30, 2022 | September 24, 2021 | |||||||||||||
| GAAP diluted earnings per share | $ | 0.28 | $ | 0.42 | $ | 1.81 | $ | 2.97 | ||||||||
| Stock-based compensation | 0.27 | 0.22 | 1.13 | 0.95 | ||||||||||||
| Amortization of acquisition-related intangibles | 0.02 | 0.04 | 0.09 | 0.10 | ||||||||||||
| Other operating income adjustments | — | — | 0.34 | (0.08 | ) | |||||||||||
| Restructuring charges | 0.05 | (0.01 | ) | 0.10 | 0.10 | |||||||||||
| Income tax adjustments | (0.08 | ) | (0.09 | ) | (0.33 | ) | (0.38 | ) | ||||||||
| Non-GAAP diluted earnings per share | $ | 0.54 | $ | 0.58 | $ | 3.14 | $ | 3.66 | ||||||||
| Weighted-average shares outstanding - diluted | 98 | 104 | 102 | 105 | ||||||||||||
| The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the first quarter of fiscal 2023 and fiscal 2023 included in this release: | ||||||||
| Operating expenses: | Q1 2023 | Fiscal 2023 | ||||||
| GAAP operating expenses (low - high end of range) | $214 - $224 | (2%) +/- year-over-year | ||||||
| Stock-based compensation | (33 | ) | (124 | ) | ||||
| Amortization of acquisition-related intangibles | (1 | ) | (4 | ) | ||||
| Non-GAAP operating expenses (low - high end of range) | $180 - $190 | +2% +/- year-over-year | ||||||
| Operating margin: | Fiscal 2023 | ||
| GAAP operating margin (low - high end of range) | 19% +/- | ||
| Stock-based compensation | 10 % | ||
| Amortization of acquisition-related intangibles | 1 % | ||
| Non-GAAP operating margin (low - high end of range) | 30% +/- | ||
| Effective tax rate: | Q1 2023 | |||
| GAAP effective tax rate (low - high end of range) | 22% - 24% | |||
| Stock-based compensation (low - high end of range) | (2%) - (1%) | |||
| Amortization of acquisition-related intangibles (low - high end of range) | (1%) - 0% | |||
| Other (low - high end of range) | (1%) - 0% | |||
| Non-GAAP effective tax rate (low - high end of range) | 19% - 21% |
| Diluted earnings per share: | Q1 2023 | |||||||
| Low | High | |||||||
| GAAP diluted earnings per share | $ | 0.46 | $ | 0.61 | ||||
| Stock-based compensation | 0.34 | 0.34 | ||||||
| Amortization of acquisition-related intangibles | 0.02 | 0.02 | ||||||
| Income tax adjustments | (0.06 | ) | (0.06 | ) | ||||
| Non-GAAP diluted earnings per share | $ | 0.76 | $ | 0.91 | ||||
| Weighted-average shares outstanding - diluted | 99 | 99 | ||||||
Investor Contact:
Maggie O’Donnell
Dolby Laboratories
914-267-7390
investor@dolby.com
Media Contact:
Karen Hartquist
Dolby Laboratories, Inc.
415-505-8357
karen.hartquist@dolby.com